No Data
Express News | Reported Sunday, IO Biotech Unveils Preclinical Results For A Vaccine That Targets TGF-β in Tumors
IO Biotech Announces Positive Findings on TGF-β-Directed Peptide Vaccine for Solid Tumors at AACR-IO Conference
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
IO Biotech Announces Preclinical Data Publication For IO112, Arginase 1-Targeting Cancer Vaccine
Express News | IO Biotech Announces The Publication of Results From A Preclinical Study Of Its Second Immune-Modulatory Therapeutic Cancer Vaccine Candidate, IO112, Targeting Arginase 1, In the Journal For Immunotherapy Of Cancer
12 Health Care Stocks Moving In Monday's Pre-Market Session
